FEBRUARY 2016 ARTICLE LIST >>
PharmaTutor (February- 2016)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 4, Issue 2)
Received On: 07/09/2015; Accepted On: 11/09/2015; Published On: 01/02/2016
AUTHOR:
Jitendra Kumar Badjatya
Deputy Manager-DRA,
Montajat Pharmaceutical Company Limited, Dammam, KSA
jeetbadjatya@gmail.com
ABSTRACT: A Generic Product must meet the standards established by China Food and Drug Administration (CFDA) to be approved for marketing in China respectively. This study covers the introduction to generic drugs, in China regulatory authorities. It also includes the requirements and registration of Generic Drugs.
Many large pharmaceutical companies have increased their presence in emerging markets in recent years like China markets is predicted to be the second largest market after US in Pharmaceuticals. China is moving past its phase as a supply market for ingredients and generic finished drugs. So, is more important to know about Regulatory considerations and Registration process of Generic Drugs. This article focuses in particular on pharmaceuticals companies, the Registration process of Generic Drugs, and their activities in the China.
How to cite this article: Badjatya JK; Regulatory requirements and registration process of Generic Drugs in China; PharmaTutor; 2016; 4(2); 13-18
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Introduction to regulatory affairs. Published in Regulatory Affairs Professional Society (RAPS) [Internet]. RAPS; 2013 [cited 2014 Dec11]. Available from:
raps.org/uploadedFiles/Site_Setup/Home_Page/About_RAPS/The_Regulatory_Profession/PDF_Framework_Whitepaper.pdf
2. Introduction to Generic Drug. Published in WHO [Internet]. WHO; 2015 [cited 2014 Dec10]. Available from:
who.int/trade/glossary/story034/en/
3. CHINA - Growing and Distinctive Pharmaceutical market [Internet] CFDA [updated 2015 Feb; Cited on 2014 Dec 15]. Available from:
eng.sfda.gov.cn/WS03/CL0756/
4. Registration Categories of Drugs and Applications [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 18]. Available from: eng.sfda.gov.cn/WS03/CL0769/98158.html
5. Steps involved in Registration of Imported Drugs in China [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 17]. Available from:
eng.sfda.gov.cn/WS03/CL0769/98162.html
6. General requirements for application dossiers [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 12]. Available from:
eng.sfda.gov.cn/WS03/CL0766/61638.html#01
7. Specific Requirements for Chemical Drugs [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 10]. Available from:
eng.sfda.gov.cn/WS03/CL0769/98162.html
8. Standards and testing [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 11]. Available from: eng.sfda.gov.cn/WS03/CL0767/61640.html
9. Clinical Study [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 06]. Available from:
eng.sfda.gov.cn/WS03/CL0767/61639.html
10. Requirement for Local Registration of Clinical Trial[Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 13]. Available from:
eng.sfda.gov.cn/WS03/CL0769/98158.html
11. Imported drug License [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 16]. Available from: eng.sfda.gov.cn/WS03/CL0768/98109.html
12. Requirements for Approval of Imported Drugs in China [Internet] CFDA; 2013 Dec 6 [Cited on 2014 Dec 18]. Available from:
eng.sfda.gov.cn/WS03/CL0769/98158.html
.png)
